Table 3.
12-month prevalence of different anxiety and depressive disorders in men who were toxoplasma seropositive or seronegative; calculated as predictive margins adjusting for age
| Psychiatric disorder | Prevalence in T. gondii seropositive (% with 95% CI)1 | Prevalence in T. gondii seronegative (% with 95% CI)1 | P-value (Wald χ2) |
|---|---|---|---|
| Panic disorder | 2.1% (1.0%–4.2%) | 1.3% (0.8%–1.9%) | 0.24 |
| Agoraphobia | 0.7% (0.2%–2.1%) | 0.5% (0.3%–0.9%) | 0.68 |
| GAD | 1.5% (0.7%–3.2%) | 1.2% (0.8%–1.9%) | 0.72 |
| Social phobia | 1.9% (0.9%–2.9%) | 1.0% (0.7%–1.5%) | 0.13 |
| Any anxiety disorder | 4.3% (2.7%–6.7%) | 3.4% (2.7%–4.2%) | 0.39 |
| MDD | 3.8% (2.3%–6.0%) | 3.3% (2.6%–4.2%) | 0.64 |
| Dysthymia | 3.2% (1.9%–5.3%) | 1.6% (1.1%–2.3%) | 0.032 |
| Any depressive disorder | 5.6% (3.7%–8.2%) | 4.3% (3.5%–5.3%) | 0.28 |
| Alcohol use disorder | 6.8% (4.7%–9.7%) | 7.9% (6.8%–9.1%) | 0.44 |
1
Adjusted for age